I D
× COMMENTARY
Digitalization Game ChangersGame Changers
The technologies associated with the Industrial Internet of Things, and…
COVER STORYIN THE NEWSNEWSFRONTSCHEMENTATOR + Show More
Chemical Engineering MagazineChementator Briefs
ANG fueling station Ingevity (North Charleston, S.C.; www.ingevity.com) has completed…
BUSINESS NEWSTECHNICAL & PRACTICALFEATURE REPORTFACTS AT YOUR FINGERTIPSTECHNOLOGY PROFILESOLIDS PROCESSINGEQUIPMENT & SERVICESFOCUSNEW PRODUCTS + Show More SHOW PREVIEWS

Comment Business & Economics

Arzeda and Zymergen collaborate on development of new molecules

By Scott Jenkins |

Zymergen Inc. (Emeryville, Calif.; www.zymergen.com) and Arzeda (Seattle, Wash.; www.arzeda.com) announced a multi-year agreement to develop strains and processes to manufacture novel, high utility molecules and materials utilizing Arzeda’s pathway and enzyme design and Zymergen’s strain construction capabilities.   
 
“The development of new materials was a major driver of technological development over the course of the 20th century.  Biology has the potential to drive materials breakthroughs in the 21st century, and Arzeda’s technology can help identify new avenues for unlocking this potential,” said Zach Serber, Zymergen’s Chief Scientific Officer. “We look forward to the results of the collaboration.”
 
“We have only started to scratch the surface of what synthetic biology can deliver in terms of new molecules and materials. Arzeda’s computational design technology opens up the ability to produce molecules with applications in transportation, medicine, and communications that are not currently biosynthetized,” said Alexandre Zanghellini, Arzeda’s Chief Executive Officer. “Uniting with Zymergen’s innovative strain design platform has the potential to help make our designs a reality. “Zymergen’s scientists are constantly pushing the envelope in synthetic biology, and we are thrilled to be working with their team.”
 
Arzeda’s Archytas™ industrial protein design software and Scylax™ computational pathway design tool will be used to identify and design new enzymatic pathways capable of producing molecules that are impossible to synthesize via conventional chemistry.  These pathway designs will be implemented and tested by Zymergen’s high-throughput strain development and testing platform.

Related Content
CAB Flat in February, ACC says
The Chemical Activity Barometer (CAB), a leading economic indicator created by the American Chemistry Council (ACC; Washington, D.C.; www.americanchemistry.com), posted…

Mettler Toledo

Tunable Diode Laser Spectroscopy in Critical Applications

Accurate and continuous O2 determination plays a pivotal role in achieving safety and process reliability in a wide range of manufacturing processes. Harsh process conditions and maintenance requirements of sampling and conditioning systems can present…

Chemical Engineering publishes FREE eletters that bring our original content to our readers in an easily accessible email format about once a week.
Subscribe Now
Reduce Explosion Risk in 2 Seconds with In Situ Oxygen Analysis
Tunable Diode Laser Spectroscopy in Critical Applications
Non-Contacting Gas Sensors Minimize the Risk of Corrosion to Plant Equipment.
5 ways to Optimize Production of Polymers and Intermediate Petrochemicals
7 Ways to Achieve Process Safety in Chemical Production

View More

Live chat by BoldChat